![](/img/cover-not-exists.png)
IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy
Motegi, Hiroaki, Kamoshima, Yuuta, Terasaka, Shunsuke, Kobayashi, Hiroyuki, Yamaguchi, Shigeru, Tanino, Mishie, Murata, Junichi, Houkin, KiyohiroVolume:
30
Language:
english
Pages:
6
Journal:
Brain Tumor Pathology
DOI:
10.1007/s10014-012-0109-x
Date:
April, 2013
File:
PDF, 520 KB
english, 2013